Khalifa Haftar in Abyar, east of Benghazi. (Esam Omran Al-Fetori / Reuters)
Khalifa Haftar in Abyar, east of Benghazi. (Esam Omran Al-Fetori / Reuters)

Libya’s chance for stability



There is no easy solution in Libya – that much has been clear since the rival militia groups that ousted Muammar Qaddafi (with Nato help) turned on each other. Today, the country has two rival parliaments and far too many groups with guns.

It is unsurprising, therefore, that many in Libya – as reported in these pages earlier this week – believe only a military council can end the political deadlock and instability and restore some semblance of a national state.

The man being touted to be the new army chief is a former general, Khalifa Haftar. He has what might be plausibly called a flexible military history: fighting alongside, then against Qaddafi, vanishing into exile for two decades in the US, before reappearing after Qaddafi’s fall. At least, however, Gen Haftar has military experience: he has fought against many of the militias that roam Libya, and has a particular distaste for religiously extreme groups.

Although a controversial figure, Gen Haftar has gained some additional legitimacy this week. Libya’s internationally recognised parliament – based in the eastern city of Tobruk rather than the capital Tripoli – on Tuesday created a new army chief post, who would lead the Libyan army. Sources in Libya indicated that Gen Haftar would be given the post, although, as yet, a formal announcement has not been made.

What this means is unclear. The UN has been sponsoring dialogue between the rival parliaments, in the hope of finding a political breakthrough. This week, the Tobruk-based parliament pulled out of the talks, accusing the Tripoli-based group Libya Dawn of – at the least – insufficient condemnation of attacks by ISIL-linked fighters.

Gen Haftar, then, may soon find himself and his fighters waging battle once more, this time in the name of the elected Libya parliament. Every avenue that Libya has explored since the end of the Qaddafi era has led to more bloodshed. It is only to be hoped that, at the end of this latest round, there is a political payoff.

Company Profile

Name: Ovasave
Started: November 2022
Founders: Majd Abu Zant and Torkia Mahloul
Based: Abu Dhabi
Sector: Healthtech
Number of staff: Three employees
Investment stage: Pre-seed
Investment: $400,000

Kill

Director: Nikhil Nagesh Bhat

Starring: Lakshya, Tanya Maniktala, Ashish Vidyarthi, Harsh Chhaya, Raghav Juyal

Rating: 4.5/5

More from Armen Sarkissian
Quick facts
  • Storstockholms Lokaltrafik (SL) offers free guided tours of art in the metro and at the stations
  • The tours are free of charge; all you need is a valid SL ticket, for which a single journey (valid for 75 minutes) costs 39 Swedish krone ($3.75)
  • Travel cards for unlimited journeys are priced at 165 Swedish krone for 24 hours
  • Avoid rush hour – between 9.30 am and 4.30 pm – to explore the artwork at leisure
While you're here

KEY HIGHLIGHTS

Healthcare spending to double to $2.2 trillion rupees

Launched a 641billion-rupee federal health scheme

Allotted 200 billion rupees for the recapitalisation of state-run banks

Around 1.75 trillion rupees allotted for privatisation and stake sales in state-owned assets

The specs

Engine: 1.8-litre 4-cyl turbo
Power: 190hp at 5,200rpm
Torque: 320Nm from 1,800-5,000rpm
Transmission: Seven-speed dual-clutch auto
Fuel consumption: 6.7L/100km
Price: From Dh111,195
On sale: Now

Dr Amal Khalid Alias revealed a recent case of a woman with daughters, who specifically wanted a boy.

A semen analysis of the father showed abnormal sperm so the couple required IVF.

Out of 21 eggs collected, six were unused leaving 15 suitable for IVF.

A specific procedure was used, called intracytoplasmic sperm injection where a single sperm cell is inserted into the egg.

On day three of the process, 14 embryos were biopsied for gender selection.

The next day, a pre-implantation genetic report revealed four normal male embryos, three female and seven abnormal samples.

Day five of the treatment saw two male embryos transferred to the patient.

The woman recorded a positive pregnancy test two weeks later. 

Pathaan

Director: Siddharth Anand 

Stars: Shah Rukh Khan, Deepika Padukone, John Abraham 

Rating: 3/5

ROUTE TO TITLE

Round 1: Beat Leolia Jeanjean 6-1, 6-2
Round 2: Beat Naomi Osaka 7-6, 1-6, 7-5
Round 3: Beat Marie Bouzkova 6-4, 6-2
Round 4: Beat Anastasia Potapova 6-0, 6-0
Quarter-final: Beat Marketa Vondrousova 6-0, 6-2
Semi-final: Beat Coco Gauff 6-2, 6-4
Final: Beat Jasmine Paolini 6-2, 6-2

SPEC SHEET: NOTHING PHONE (2)

Display: 6.7” LPTO Amoled, 2412 x 1080, 394ppi, HDR10+, Corning Gorilla Glass

Processor: Qualcomm Snapdragon 8+ Gen 2, octa-core; Adreno 730 GPU

Memory: 8/12GB

Capacity: 128/256/512GB

Platform: Android 13, Nothing OS 2

Main camera: Dual 50MP wide, f/1.9 + 50MP ultrawide, f/2.2; OIS, auto-focus

Main camera video: 4K @ 30/60fps, 1080p @ 30/60fps; live HDR, OIS

Front camera: 32MP wide, f/2.5, HDR

Front camera video: Full-HD @ 30fps

Battery: 4700mAh; full charge in 55m w/ 45w charger; Qi wireless, dual charging

Connectivity: Wi-Fi, Bluetooth 5.3, NFC (Google Pay)

Biometrics: Fingerprint, face unlock

I/O: USB-C

Durability: IP54, limited protection

Cards: Dual-nano SIM

Colours: Dark grey, white

In the box: Nothing Phone (2), USB-C-to-USB-C cable

Price (UAE): Dh2,499 (12GB/256GB) / Dh2,799 (12GB/512GB)

SPECS

Engine: Two-litre four-cylinder turbo
Power: 235hp
Torque: 350Nm
Transmission: Nine-speed automatic
Price: From Dh167,500 ($45,000)
On sale: Now

COMPANY PROFILE

Name: Haltia.ai
Started: 2023
Co-founders: Arto Bendiken and Talal Thabet
Based: Dubai, UAE
Industry: AI
Number of employees: 41
Funding: About $1.7 million
Investors: Self, family and friends

Herc's Adventures

Developer: Big Ape Productions
Publisher: LucasArts
Console: PlayStation 1 & 5, Sega Saturn
Rating: 4/5

ARM IPO DETAILS

Share price: Undisclosed

Target raise: $8 billion to $10 billion

Projected valuation: $60 billion to $70 billion (Source: Bloomberg)

Lead underwriters: Barclays, Goldman Sachs Group, JPMorgan Chase and Mizuho Financial Group